【摘要】：【目的】探討肝硬化病例的臨床特征和輸血狀況并分析其合理性。【方法】自行設(shè)計(jì)調(diào)查表,收集所有新入院肝硬化病例一般情況、臨床特征、血液輸注情況,以及吸煙、飲酒等生活行為習(xí)慣,并進(jìn)行隨訪。【結(jié)果】共收集198例肝硬化病例,其中34.8%(69/198)的病例在住院期間輸注了不同種類的血液品種,合計(jì)輸血371次,其中52.2%的輸血病例(36/69)在住院期間輸注過2種及以上血液。69例輸血肝硬化病例中,首次血液輸注以治療和預(yù)防為目的的病例分別為11例和58例;18例輸注紅細(xì)胞,輸注總量為90.5 U。INR1.3的110例肝硬化病例中,分別有54.55%(60/110)、60.91%(67/110)未輸注新鮮和冰凍血漿,而在INR≤1.3的病例中有2.27%(2/88)的病例輸注了血漿。纖維蛋白原小于1.0 g/L的病例中,輸注冷沉淀的病例占29.41%(5/17);大于1.0 g/L的病例中,輸注冷沉淀的病例占3.87%(7/181)。【結(jié)論】血液輸注是肝硬化患者較常用的治療手段,經(jīng)驗(yàn)性和預(yù)防性輸血較普遍,應(yīng)采取更科學(xué)的限制性輸血策略以優(yōu)化輸血治療方案。
[Abstract]:[objective] to investigate the clinical characteristics and blood transfusion status of patients with liver cirrhosis and analyze their rationality. [methods] A self-designed questionnaire was designed to collect the general, clinical features, blood transfusion and smoking of all the newly admitted patients with cirrhosis. [results] A total of 198 cases of liver cirrhosis were collected. 34.8% (69 / 198) of the cases received different kinds of blood transfusion during hospitalization, and 371 blood transfusions were made. Among them, 52.2% (36 / 69) of blood transfusion cases (36 / 69) had been infused with 2 or more kinds of blood during hospitalization. Among 69 cases of cirrhosis of blood transfusion, 11 cases were treated with the first blood transfusion and 58 cases were treated with prevention. Among 18 cases of liver cirrhosis, 54.55% (60 / 110) and 60.91% (67 / 110) were not infused with fresh or frozen plasma respectively. Plasma was injected in 2.27% (2 / 88) of patients with INR 鈮，

本文編號(hào)：2296405